Junjie Xiao Selected Research

Biomarkers (Surrogate Marker)

6/2023	Diagnosis of acute myocardial infarction using a combination of circulating circular RNA cZNF292 and clinical information based on machine learning.
1/2021	Mir-30d Regulates Cardiac Remodeling by Intracellular and Paracrine Signaling.
1/2020	The anti-microbial peptide LL-37/CRAMP levels are associated with acute heart failure and can attenuate cardiac dysfunction in multiple preclinical models of heart failure.
10/2018	MicroRNAs in heart and circulation during physical exercise.
1/2018	Noncoding RNAs in Muscle Atrophy.
1/2017	MicroRNAs Mediate Beneficial Effects of Exercise in Heart.
1/2017	Circulating Exosomes in Cardiovascular Diseases.
1/2017	Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases.
1/2017	Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure.
10/2016	Inhibition of miR-155 Protects Against LPS-induced Cardiac Dysfunction and Apoptosis in Mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Junjie Xiao Research Topics

Disease

23	Cardiovascular Diseases (Cardiovascular Disease) 10/2023 - 01/2012
23	Heart Failure 12/2021 - 01/2010
15	Myocardial Infarction 06/2023 - 08/2012
13	Muscular Atrophy (Muscle Atrophy) 03/2023 - 01/2017
11	Hypertrophy 10/2023 - 07/2010
10	Reperfusion Injury 05/2024 - 04/2010
8	Fibrosis (Cirrhosis) 01/2024 - 04/2013
8	Atrial Fibrillation 01/2014 - 12/2006
7	Inflammation (Inflammations) 06/2023 - 01/2016
7	Ischemia 01/2019 - 01/2010
6	Neoplasms (Cancer) 01/2023 - 01/2017
5	Heart Diseases (Heart Disease) 04/2024 - 03/2010
5	Pathologic Processes 01/2023 - 01/2014
4	Atrophy 01/2024 - 01/2017
4	Cardiomegaly (Heart Hypertrophy) 10/2023 - 10/2018
4	Myocardial Ischemia (Ischemic Heart Diseases) 10/2023 - 07/2009
4	Infarction (Infarctions) 01/2023 - 05/2011
4	Hypertension (High Blood Pressure) 01/2021 - 01/2017
4	Cardiac Arrhythmias (Arrythmia) 01/2021 - 07/2009
3	Cardiotoxicity 01/2024 - 01/2022
3	Hypoxia (Hypoxemia) 10/2023 - 01/2011
3	Necrosis 06/2015 - 12/2012
2	Obesity 06/2023 - 01/2023
2	Body Weight (Weight, Body) 01/2023 - 01/2014
2	Insulin Resistance 01/2023 - 01/2023
2	Cachexia 12/2021 - 01/2017
2	Peripheral Arterial Disease 01/2021 - 01/2021
2	Ventricular Remodeling 01/2021 - 01/2017
2	Atherosclerosis 01/2020 - 01/2017
2	Muscle Cramp (Cramp) 01/2020 - 01/2019
2	Colorectal Neoplasms (Colorectal Cancer) 09/2017 - 01/2017
2	Stroke (Strokes) 01/2017 - 08/2012
2	Coronary Artery Disease (Coronary Atherosclerosis) 01/2017 - 08/2012
2	Sepsis (Septicemia) 10/2016 - 01/2016
2	Alcoholic Fatty Liver 02/2016 - 01/2016
2	Pulmonary Embolism 08/2012 - 09/2011
1	Coronary Disease (Coronary Heart Disease) 01/2024
1	COVID-19 06/2023
1	Death (Near-Death Experience) 06/2023
1	Lung Injury 06/2023
1	Iron Overload 06/2023
1	Sarcopenia 01/2023
1	Fatty Liver 01/2023

Drug/Important Bio-Agent (IBA)

29	MicroRNAs (MicroRNA)IBA 03/2023 - 03/2010
15	Biomarkers (Surrogate Marker)IBA 06/2023 - 09/2011
9	Circular RNAIBA 10/2023 - 01/2018
9	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2010
7	Angiotensin IIIBA 03/2023 - 01/2020
6	mouse MIRN29 microRNAIBA 03/2023 - 01/2017
5	RNA (Ribonucleic Acid)IBA 04/2024 - 11/2022
4	Untranslated RNA (Noncoding RNA)IBA 05/2023 - 12/2015
4	Dexamethasone (Maxidex)FDA LinkGeneric 03/2023 - 01/2017
4	Insulin (Novolin)FDA Link 01/2023 - 01/2014
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024 - 01/2022
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2023 - 01/2021
3	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 01/2023 - 01/2020
3	Therapeutic UsesIBA 01/2023 - 01/2016
3	Long Noncoding RNAIBA 12/2021 - 01/2021
3	Fluorouracil (Carac)FDA LinkGeneric 11/2017 - 01/2017
3	Atrial Natriuretic Factor (ANF)IBA 01/2017 - 01/2014
3	qiliqiangxinIBA 02/2015 - 01/2015
3	Messenger RNA (mRNA)IBA 01/2015 - 01/2014
3	triphenyltetrazoliumIBA 01/2015 - 01/2014
3	Paclitaxel (Taxol)FDA LinkGeneric 05/2011 - 01/2010
3	Cholinergic Agents (Cholinergics)IBA 11/2010 - 04/2010
2	Glucose (Dextrose)FDA LinkGeneric 05/2024 - 01/2019
2	6-methyladenineIBA 06/2023 - 11/2022
2	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2023 - 11/2010
2	Mitochondrial DNA (mtDNA)IBA 01/2023 - 01/2015
2	PPAR gammaIBA 11/2022 - 03/2021
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 07/2022 - 01/2020
2	Hormones (Hormone)IBA 12/2021 - 05/2018
2	CalciumIBA 01/2021 - 01/2010
2	Peptides (Polypeptides)IBA 01/2020 - 01/2019
2	Antimicrobial PeptidesIBA 01/2020 - 01/2019
2	CathelicidinsIBA 01/2020 - 01/2019
2	Estrogens (Estrogen)FDA Link 05/2018 - 07/2009
2	Phosphotransferases (Kinase)IBA 01/2017 - 01/2016
2	LipopolysaccharidesIBA 10/2016 - 01/2016
2	fibroblast growth factor 21IBA 02/2016 - 01/2016
2	Annexin A5IBA 02/2015 - 12/2012
2	Propidium (Propidium Iodide)IBA 02/2015 - 12/2012
2	Bromodeoxyuridine (BrdU)IBA 04/2014 - 12/2012
2	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2014 - 01/2014
2	Adenosine Triphosphate (ATP)IBA 07/2010 - 04/2010
2	Fura-2 (Fura 2)IBA 07/2010 - 04/2010
1	Fc gamma receptor IIBIBA 01/2024
1	RNA Splicing FactorsIBA 10/2023
1	N-methyladenosineIBA 06/2023
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 01/2023
1	Diosmin (Daflon)IBA 01/2023
1	CCAAT-Enhancer-Binding ProteinsIBA 01/2023

Therapy/Procedure

15	Therapeutics 06/2023 - 01/2015
6	Denervation 10/2023 - 01/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 03/2021 - 01/2015
3	Drug Therapy (Chemotherapy) 01/2021 - 01/2015
3	Cardiac Resynchronization Therapy 01/2017 - 06/2015
2	Transplantation 04/2014 - 04/2013
1	Cardiac Rehabilitation 01/2024
1	Immunomodulation 01/2023